ArticleDer Nervenarzt2026
[Inpatient treatment of substance use disorders : Structures and treatment strategies: results of a nationwide survey of treatment facilities].
Article in Der Nervenarzt, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSystematic data on the implementation of key elements of inpatient treatment for substance use disorders in Germany are still limited.
objectiveTo systematically assess inpatient care practices with a focus on pharmacological strategies, relapse management, temporal aspects of (qualified) withdrawal treatment, and the management of psychiatric comorbidities, as well as differences between acute care and rehabilitation settings and regional variations. MATERIALS AND
methodsNationwide, anonymized online survey of 500 inpatient facilities (acute care and rehabilitation clinics). Structural characteristics, treatment strategies, and organizational aspects were assessed. Data were analyzed descriptively and inferentially (χ
resultsA total of 112 facilities participated (68 acute care and 44 rehabilitation clinics). Treatment services covered a broad range of substances. Evidence-based pharmacotherapy for alcohol-related disorders was often not initiated or continued, particularly in rehabilitation settings. Access for patients receiving opioid substitution treatment was limited in these settings. Relapses were frequently managed on an individualized and motivation-based basis; however, in cases of repeated unreported relapse, treatment was often terminated. Temporal aspects of qualified withdrawal treatment varied considerably, with regional differences. Psychiatric comorbidities were widely addressed.
conclusionCare practices are heterogeneous, with relevant deviations from evidence-based recommendations, particularly regarding pharmacological strategies and access for specific patient groups. There is a need for more consistently evidence-based and patient-centered inpatient treatment approaches.
Indexed as
Identifiers
42771037What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.